Physician profile
Michael Morse
NPI 1225320112
$15,771.00
in general payments reported to CMS, 2019-2025
6 companies · $6,915 in 2025
The $6,915 reported for 2025 was more than what 95% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8.03 · 2020: $24.46 · 2021: $17.84 · 2022: $17.80 · 2024: $8,788 · 2025: $6,915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,945 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,460 · Travel and Lodging: $3,457 · Food and Beverage: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,945.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,460.00 |
| Travel and Lodging | $3,456.79 |
| Food and Beverage | $841.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $8,787.59 | 2024 | |
| Collegium Pharmaceutical, INC. | $6,915.28 | 2025 | Jornay Pm |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.46 | 2020 | |
| Supernus Pharmaceuticals, INC. | $17.84 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.80 | 2022 | |
| Journey Medical Corporation | $8.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Morse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.